RLAY

NASDAQ 已收盘

Relay Therapeutics

15.91 USD
▼-0.60-3.63%
盘后 15.69 -1.38%
2026-11-19
市值
$3.56B
市盈率
—
EPS
-1.51
股息率
—
52 周区间
6.28 – 21.27
成交量
1.88M
Beta
1.74
目标价
28.25
52W 低 6.2852W 高 21.27
价格走势

公司简介

Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It transforms the drug discovery process with a focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company’s lead product candidates include RLY-2608, a pan-mutant and isoform-selective phosphoinostide 3 kinase alpha, or PI3Kα, inhibitor that is in clinical development for the treatment of breast cancer, solid tumor, and vascular malformations; and αGal chaperone for Fabry diseases. It also develops R...